8.465
前日終値:
$8.64
開ける:
$8.67
24時間の取引高:
1.50M
Relative Volume:
1.26
時価総額:
$1.10B
収益:
$175.51M
当期純損益:
$-78.02M
株価収益率:
-15.97
EPS:
-0.53
ネットキャッシュフロー:
$-34.18M
1週間 パフォーマンス:
+8.49%
1か月 パフォーマンス:
+8.35%
6か月 パフォーマンス:
-7.36%
1年 パフォーマンス:
+48.77%
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
AUPH
Aurinia Pharmaceuticals Inc
|
8.465 | 1.10B | 175.51M | -78.02M | -34.18M | -0.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
444.19 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
523.15 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
326.45 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
546.62 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
242.53 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-17 | 開始されました | BTIG Research | Buy |
2020-05-05 | 開始されました | Cowen | Outperform |
2020-01-10 | 開始されました | Jefferies | Buy |
2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
2016-06-30 | 開始されました | H.C. Wainwright | Buy |
2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA
California State Teachers Retirement System Sells 13,824 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by Bank of America Corp DE - Defense World
Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock? - MSN
As Edmonton biotech industry booms, Launa Aspeslet steps up to guide further success - Taproot Edmonton
Wellington Management Group LLP Buys New Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress - mx.advfn.com
Millennium Management LLC Increases Stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SDIG, AUPH and LICY - ACCESS Newswire
(AUPH) Trading Signals - news.stocktradersdaily.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.27 Million Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - InsuranceNewsNet
Ameriprise Financial Inc. Acquires 26,981 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AUPH, IRNT and RSKD - ACCESS Newswire
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? - MSN
BNP Paribas Financial Markets Sells 14,003 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Is The Options Market Predicting A Spike In Aurinia Pharmaceuticals (AUPH) Stock? - Barchart.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Nuveen Asset Management LLC Increases Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Cetera Investment Advisers Purchases 2,000 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
(AUPH) Technical Data - news.stocktradersdaily.com
Deutsche Bank AG Purchases 50,575 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert - Benzinga
Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial R - GuruFocus
Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial Results | AUPH Stock News - GuruFocus
Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study - TipRanks
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Leerink Partnrs Has Positive Outlook of AUPH Q2 Earnings - Defense World
Aurinia Pharmaceuticals Approves New Equity Incentive Plan - TipRanks
Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Transcript : Aurinia Pharmaceuticals Inc.Shareholder/Analyst Call - marketscreener.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - MSN
Aurinia Pharmaceuticals Financial Update and Strategic Growth Plans - Zenopa
Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus
Price T Rowe Associates Inc. MD Has $468,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia outlines $250M–$260M 2025 revenue target as LUPKYNIS sales climb 25% and operational efficiency improves - MSN
Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus
Company News for May 13, 2025 - Yahoo Finance
Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks
Document - SEC.gov
Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks
Aurinia: Q1 Earnings Snapshot - MySA
Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga
Leerink maintains Aurinia stock Outperform with $10 target - Investing.com
Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens - Investing.com India
AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
Aurinia Pharmaceuticals Inc (AUPH) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Greenleaf Peter | Chief Executive Officer |
Mar 03 '25 |
Sale |
8.00 |
195,593 |
1,564,744 |
1,953,892 |
Greenleaf Peter | Chief Executive Officer |
Mar 04 '25 |
Sale |
7.92 |
164,947 |
1,306,380 |
1,788,945 |
Keenan Greg | Chief Medical Officer |
Mar 03 '25 |
Sale |
8.00 |
12,239 |
97,912 |
161,789 |
Miller Joseph M | Chief Financial Officer |
Mar 03 '25 |
Sale |
8.00 |
61,859 |
494,872 |
633,515 |
Miller Joseph M | Chief Financial Officer |
Mar 04 '25 |
Sale |
7.92 |
56,154 |
444,740 |
577,361 |
Robertson Stephen P. | EVP, General Counsel |
Mar 03 '25 |
Sale |
8.00 |
64,872 |
518,976 |
566,883 |
Robertson Stephen P. | EVP, General Counsel |
Mar 04 '25 |
Sale |
7.92 |
57,607 |
456,247 |
509,276 |
Donley Matthew Maxwell | Chief Operating Officer |
Mar 03 '25 |
Sale |
8.00 |
65,902 |
527,216 |
739,456 |
Donley Matthew Maxwell | Chief Operating Officer |
Mar 04 '25 |
Sale |
7.92 |
58,991 |
467,209 |
680,465 |
TANG KEVIN | Director |
Mar 04 '25 |
Buy |
7.96 |
748,038 |
5,953,304 |
10,029,500 |
大文字化:
|
ボリューム (24 時間):